10.3 Postpartum Venous Thromboembolism
Key Takeaways
- The postpartum period confers a 15- to 20-fold increased venous thromboembolism risk, with the absolute risk peaking in the first 3 to 6 weeks.
- More than 80 percent of pregnancy-related deep vein thromboses occur in the left leg because the right common iliac artery compresses the left common iliac vein.
- Homan sign is insensitive, non-specific, and potentially hazardous, and should not be used diagnostically.
- A calf circumference difference of 3 cm or more measured 10 cm below the tibial tuberosity is the validated Wells criterion prompting compression duplex ultrasonography.
- Compression duplex ultrasonography with color Doppler is the diagnostic gold standard, with failure of venous compression establishing intraluminal thrombus.
Last updated: September 2026
Postpartum Venous Thromboembolism (VTE)
Venous thromboembolism—encompassing Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)—is a leading contributor to maternal mortality in developed nations.
The Impact of the Puerperium
While pregnancy increases the risk of VTE approximately 4- to 5-fold, the postpartum period confers a 15- to 20-fold increased risk compared to non-pregnant controls. The absolute risk peaks during the first 3 to 6 weeks postpartum.
Virchow's Triad in the Postpartum State
- Hypercoagulability: Maternal clotting factor production rises markedly during late pregnancy and the puerperium (marked elevations in fibrinogen [Factor I], Factor VII, Factor VIII, Factor X, and von Willebrand factor), coupled with a profound decline in Protein S activity and acquired activated protein C resistance. This physiological adaptation evolved to minimize fatal peripartum hemorrhage.
- Venous Stasis: High circulating progesterone promotes smooth muscle relaxation and venous capacitative pooling. Furthermore, the persistent mechanical compression of the pelvic veins and inferior vena cava by the enlarged uterus, compounded by post-cesarean immobility, promotes venous pooling.
- Vascular Endothelial Injury: Mechanical shearing and venous micro-trauma occur during placental separation, uterine involution, operative vaginal birth, or cesarean hysterotomy.
Deep Vein Thrombosis (DVT)
- Anatomic Distribution: Over 80% of pregnancy- and postpartum-related DVTs occur in the LEFT lower extremity. This marked left-sided predilection results from the compression of the left common iliac vein where it is crossed anteriorly by the pulsating right common iliac artery (May-Thurner anatomical phenomenon).
- Clinical Presentation: Acute, unilateral lower extremity pain, persistent calf cramping, localized warmth, erythema, and pitting edema.
- Diagnostic Physical Exam: Measure calf circumference bilaterally 10 cm below the tibial tuberosity. A circumference discrepancy of 3 cm or more is the validated Wells-criteria threshold and should prompt imaging; smaller asymmetries are common postpartum and are interpreted alongside pain, warmth, and risk factors.
- AMCB Exam Warning: Homans' sign (calf pain elicited on passive foot dorsiflexion) is unreliable, insensitive, non-specific, and theoretically hazardous as forceful maneuvers may dislodge an unstable clot. Do not rely on Homans' sign for diagnosis.
- Diagnostic Gold Standard: Compression duplex ultrasonography with color Doppler of the proximal lower extremity deep veins (common femoral, femoral, and popliteal veins). Failure of the vein to fully compress under ultrasound transducer pressure establishes definitive intraluminal thrombus.
Pulmonary Embolism (PE)
- Pathophysiology: Thrombi from pelvic or proximal lower extremity veins detach and embolize through the vena cava and right heart into the pulmonary arterial bed, causing acute mechanical obstruction, ventilation-perfusion mismatch, right ventricular strain, and hemodynamic instability.
- Clinical Presentation: Sudden-onset dyspnea (the most common presenting symptom), pleuritic chest pain, tachypnea (respiratory rate >20 bpm), persistent tachycardia (heart rate >100 bpm), apprehension/anxiety, non-productive cough, hemoptysis, and in severe cases, syncope, cyanosis, and cardiovascular collapse.
- Diagnostic Evaluation:
- D-Dimer Limitations: Serum D-dimer levels are physiologically elevated throughout normal pregnancy and the puerperium. Therefore, a positive D-dimer is clinically non-specific. However, a negative high-sensitivity D-dimer has a high negative predictive value.
- Imaging Modalities:
- Chest Radiograph (CXR): Initial step to exclude pneumonia, pneumothorax, or pulmonary edema.
- Computed Tomography Pulmonary Angiography (CTPA): The diagnostic imaging of choice for suspected pulmonary embolism in the postpartum period. Provides rapid, definitive visualization of pulmonary arterial filling defects with minimal radiation exposure.
- Ventilation-Perfusion (V/Q) Scan: Utilized if the chest radiograph is completely normal and CTPA is contraindicated (e.g., severe iodinated contrast allergy or acute renal failure).
Therapeutic Anticoagulation & Lactation Compatibility
| Anticoagulant Class & Agent | Dosing & Monitoring | Mechanism of Action | Lactation Safety Profile |
|---|---|---|---|
| Low-Molecular-Weight Heparin (LMWH, Enoxaparin / Lovenox) | Therapeutic: 1 mg/kg SC every 12 hours (or 1.5 mg/kg SC once daily). Monitor anti-Xa levels if renal impairment or extreme weights. | Potentiates antithrombin III, selectively inactivating factor Xa. | FULLY COMPATIBLE with Breastfeeding. Large molecular weight and negative charge prevent excretion into breast milk; completely safe for nursing neonates. |
| Unfractionated Heparin (UFH) | IV bolus (80 units/kg) followed by continuous infusion titrated to aPTT 1.5 to 2.5 times control. | Inactivates thrombin (factor IIa) and factor Xa via antithrombin. | FULLY COMPATIBLE with Breastfeeding. Does not cross into breast milk due to high molecular weight and ionic charge. |
| Warfarin (Coumadin) | Oral dosing titrated to target International Normalized Ratio (INR) 2.0 to 3.0. | Inhibits vitamin K epoxide reductase, blocking factors II, VII, IX, X, and proteins C & S. | FULLY COMPATIBLE with Breastfeeding. Highly polar and extensively protein-bound (99%); does not pass into breast milk in clinically significant amounts. Safe in lactation (strictly contraindicated in pregnancy). |
| Direct Oral Anticoagulants (DOACs: Apixaban, Rivaroxaban, Dabigatran) | Oral fixed dosing; no routine laboratory monitoring required. | Direct reversible inhibition of factor Xa (apixaban, rivaroxaban) or direct thrombin inhibition (dabigatran). | NOT RECOMMENDED / CONTRAINDICATED during Breastfeeding. DOACs transfer into breast milk in variable concentrations; clinical safety in the nursing infant is unestablished. Avoid in lactating patients. |
Test Your Knowledge
A patient 10 days after cesarean birth reports 2 days of left calf pain and swelling. The left calf measures 4 cm larger than the right 10 cm below the tibial tuberosity, and the leg is warm with pitting edema. What is the appropriate next step?
A
B
C
D